Akèy › Anplwayè › Institute of Nuclear Medicine Inc.
Institute of Nuclear Medicine Inc.: Salè H-1B ak pajon
Institute of Nuclear Medicine Inc. depoze 3 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 3. Medyèn salè yo ofri a: $170,000.
Èske Institute of Nuclear Medicine Inc. pajone visa H-1B?
Institute of Nuclear Medicine Inc. depoze 3 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Aug 19, 2025. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Lead Medical Physicist- Radiopharmaceutical Therapy Research | 2 | $170,769 |
| Research Scientist - Radiopharmaceutical Therapy | 1 | $79,000 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2024 | 1 | $170,000 |
| FY2025 | 1 | $79,000 |
| FY2026 | 1 | $171,538 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Research Scientist - Radiopharmaceutical Therapy | $79,000 Nivo I | Bethesda, MD | Aug 19, 2025 | Sep 10, 2025 | Certifye |
| Lead Medical Physicist- Radiopharmaceutical Therapy Research | $171,538 Nivo IV | Bethesda, MD | Nov 15, 2024 | Nov 15, 2024 | Certifye, apre retire |
| Lead Medical Physicist- Radiopharmaceutical Therapy Research | $170,000 Nivo IV | Glen Burnie, MD | Feb 6, 2024 | Apr 1, 2024 | Certifye |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).